Human immunodeficiency virus type 1 Vif inhibits packaging and antiviral activity of a degradation-resistant APOBEC3G variant. 2007

Sandrine Opi, and Sandra Kao, and Ritu Goila-Gaur, and Mohammad A Khan, and Eri Miyagi, and Hiroaki Takeuchi, and Klaus Strebel
Laboratory of Molecular Microbiology, Viral Biochemistry Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 4, Room 310, 4 Center Drive, MSC 0460, Bethesda, Maryland 20892-0460, USA.

Human immunodeficiency virus type 1 (HIV-1) Vif counteracts the antiviral activity of the human cytidine deaminase APOBEC3G (APO3G) by inhibiting its incorporation into virions. This has been attributed to the Vif-induced degradation of APO3G by cytoplasmic proteasomes. We recently demonstrated that although APO3G has a natural tendency to form RNA-dependent homo-multimers, multimerization was not essential for encapsidation into HIV-1 virions or antiviral activity. We now demonstrate that a multimerization-defective APO3G variant (APO3G C97A) is able to assemble into RNase-sensitive high-molecular-mass (HMM) complexes, suggesting that homo-multimerization of APO3G and assembly into HMM complexes are unrelated RNA-dependent processes. Interestingly, APO3G C97A was highly resistant to Vif-induced degradation even though the two proteins were found to interact in coimmunoprecipitation experiments and exhibited partial colocalization in transfected HeLa cells. Surprisingly, encapsidation and antiviral activity of APO3G C97A were both inhibited by Vif despite resistance to degradation. These results demonstrate that targeting of APO3G to proteasome degradation and interference with viral encapsidation are distinct functional properties of Vif.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009700 Nucleoside Deaminases Catalyze the hydrolysis of nucleosides with the elimination of ammonia. Deaminases, Nucleoside
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D012097 Repressor Proteins Proteins which maintain the transcriptional quiescence of specific GENES or OPERONS. Classical repressor proteins are DNA-binding proteins that are normally bound to the OPERATOR REGION of an operon, or the ENHANCER SEQUENCES of a gene until a signal occurs that causes their release. Repressor Molecules,Transcriptional Silencing Factors,Proteins, Repressor,Silencing Factors, Transcriptional
D003564 Cytidine Deaminase An enzyme that catalyzes the deamination of cytidine, forming uridine. EC 3.5.4.5. Cytidine Aminohydrolase,Aminohydrolase, Cytidine,Deaminase, Cytidine
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071480 APOBEC-3G Deaminase An APOBEC deaminase that functions as an inhibitor of RETROVIRIDAE replication and inhibits the mobility of RETROTRANSPOSONS via deaminase-dependent and independent mechanisms. It is selective for SINGLE-STRANDED DNA and does not deaminate double-stranded DNA or single or DOUBLE-STRANDED RNA. It exhibits potent antiviral activity against VIF PROTEIN deficient HIV-1 through the creation of hypermutations in the VIRAL DNA. It also has anti-viral activity against SIMIAN IMMUNODEFICIENCY VIRUSES and HEPATITIS B VIRUS. APOBEC-3G Protein,APOBEC-3G dC-dU Editing Enzyme,APOBEC-Related Cytidine Deaminase,APOBEC-Related Protein,APOBEC3G Deaminase,APOBEC3G Protein,CEM15 Protein,APOBEC 3G Deaminase,APOBEC 3G Protein,APOBEC 3G dC dU Editing Enzyme,APOBEC Related Cytidine Deaminase,APOBEC Related Protein,Cytidine Deaminase, APOBEC-Related,Deaminase, APOBEC-3G,Deaminase, APOBEC3G
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014771 Virion The infective system of a virus, composed of the viral genome, a protein core, and a protein coat called a capsid, which may be naked or enclosed in a lipoprotein envelope called the peplos. Virus Particle,Viral Particle,Viral Particles,Particle, Viral,Particle, Virus,Particles, Viral,Particles, Virus,Virions,Virus Particles

Related Publications

Sandrine Opi, and Sandra Kao, and Ritu Goila-Gaur, and Mohammad A Khan, and Eri Miyagi, and Hiroaki Takeuchi, and Klaus Strebel
November 2003, Journal of virology,
Sandrine Opi, and Sandra Kao, and Ritu Goila-Gaur, and Mohammad A Khan, and Eri Miyagi, and Hiroaki Takeuchi, and Klaus Strebel
December 2007, Journal of virology,
Sandrine Opi, and Sandra Kao, and Ritu Goila-Gaur, and Mohammad A Khan, and Eri Miyagi, and Hiroaki Takeuchi, and Klaus Strebel
February 2004, Journal of virology,
Sandrine Opi, and Sandra Kao, and Ritu Goila-Gaur, and Mohammad A Khan, and Eri Miyagi, and Hiroaki Takeuchi, and Klaus Strebel
January 2009, Journal of virology,
Sandrine Opi, and Sandra Kao, and Ritu Goila-Gaur, and Mohammad A Khan, and Eri Miyagi, and Hiroaki Takeuchi, and Klaus Strebel
June 2018, Journal of virology,
Sandrine Opi, and Sandra Kao, and Ritu Goila-Gaur, and Mohammad A Khan, and Eri Miyagi, and Hiroaki Takeuchi, and Klaus Strebel
June 2010, Journal of virology,
Sandrine Opi, and Sandra Kao, and Ritu Goila-Gaur, and Mohammad A Khan, and Eri Miyagi, and Hiroaki Takeuchi, and Klaus Strebel
February 2009, Journal of virology,
Sandrine Opi, and Sandra Kao, and Ritu Goila-Gaur, and Mohammad A Khan, and Eri Miyagi, and Hiroaki Takeuchi, and Klaus Strebel
June 2009, Journal of virology,
Sandrine Opi, and Sandra Kao, and Ritu Goila-Gaur, and Mohammad A Khan, and Eri Miyagi, and Hiroaki Takeuchi, and Klaus Strebel
May 2010, Journal of virology,
Sandrine Opi, and Sandra Kao, and Ritu Goila-Gaur, and Mohammad A Khan, and Eri Miyagi, and Hiroaki Takeuchi, and Klaus Strebel
June 2006, Journal of virology,
Copied contents to your clipboard!